GlassScriptPhysician profile
Peter H Grossman
NPI 1255336756
$9,919.31
in general payments reported to CMS, 2019-2025
28 companies · $1,475 in 2025
The $1,475 reported for 2025 was more than what 80% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,358 · 2020: $5,228 · 2021: $700 · 2022: $783 · 2023: $239 · 2024: $136 · 2025: $1,475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,850.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $4,865.99 | 2020-2022 | |
| Musculoskeletal Transplant Foundation INC. | $1,373.01 | 2019-2022 | |
| Lumenis Be INC | $387.54 | 2025 | M22 |
| Smith+Nephew, INC. | $354.51 | 2019-2025 | Oasis, Grafix, Versajet |
| Mallinckrodt Enterprises LLC | $350.24 | 2019 | |
| Avita Medical Americas, LLC | $257.12 | 2019-2025 | Permeaderm, Recell, Cohealyx |
| Polynovo North America LLC | $212.85 | 2020-2025 | Novosorb Btm |
| Access Pro Medical, LLC | $197.08 | 2025 | Matriderm |
| Galderma Laboratories, L.P. | $182.42 | 2019-2023 | |
| Biotissue Holdings INC. | $180.50 | 2024-2025 | |
| Allergan, INC. | $179.57 | 2019-2021 | |
| Davol INC. | $163.65 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $160.26 | 2023-2025 | Dupixent |
| Acelrx Pharmaceuticals, INC. | $155.68 | 2021-2022 | |
| Ethicon US, LLC | $150.00 | 2025 | Vistaseal |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $148.17 | 2021 | |
| Medline Industries LP | $145.04 | 2019 | |
| Abbvie INC. | $141.43 | 2023-2025 | |
| Aroa Biosurgery Incorporated | $68.75 | 2025 | |
| Acell, INC. | $47.19 | 2020 | |
| Organogenesis INC. | $43.67 | 2019-2020 | |
| Motiva USA, LLC | $27.34 | 2025 | |
| Vertical Pharmaceuticals, LLC | $23.61 | 2023 | Dsuvia |
| Kerecis Limited | $22.33 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Sientra, INC. | $22.14 | 2022 | |
| Misonix INC | $20.89 | 2021 | |
| Kci USA, INC. | $19.22 | 2022 | |
| Baxter Healthcare | $19.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Grossman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.